Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Adrienne A.M. Zandbergen"'
Autor:
Diederik W.J. Dippel, Elizabeth Osei, Laus J.M.M. Mulder, Hester F. Lingsma, Susanne Fonville, P. J. A. M. Brouwers, Peter J. Koudstaal, Heleen M. den Hertog, Adrienne A.M. Zandbergen
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases, 29(6):104815. W.B. Saunders
Background: Impaired glucose tolerance (IGT) in patients with ischemic stroke can return to normal, reflecting an acute stress response, or persist. Persistent IGT is associated with an increased risk of recurrent stroke, other cardiovascular disease
Publikováno v:
European Journal of Internal Medicine, 55, 6-11. Elsevier
Prediabetes is an intermediate metabolic state between normal glucose metabolism and diabetes mellitus. Patients with prediabetes have an increased risk (of up to 70%) of developing type 2 diabetes. Prediabetes is highly prevalent in patient with mac
Autor:
Adrie J.M. Verhoeven, Monique T. Mulder, Hans E. van der Wiel, M. Rashid, Athumani A. Athumani, Eric J.G. Sijbrands, Yvonne van Beek-Nieuwland, Reinier Timman, Kirsten A. Berk, Adrienne A.M. Zandbergen
Publikováno v:
Trials, 19:379. BioMed Central Ltd.
Trials
Trials, Vol 19, Iss 1, Pp 1-9 (2018)
Trials
Trials, Vol 19, Iss 1, Pp 1-9 (2018)
Background Patients with type 2 diabetes mellitus (T2D) are prone to micro- and macro-vascular complications. Monomeric and oligomeric flavanols (MOF) isolated from grape seeds (Vitis vinifera) have been linked to improved endothelial function and va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1342850abaccb6c3797ac06b0e04042
https://pure.eur.nl/en/publications/b7616a80-3e2a-4ae8-8f75-7d50f6098a5a
https://pure.eur.nl/en/publications/b7616a80-3e2a-4ae8-8f75-7d50f6098a5a
Autor:
Diederik W.J. Dippel, Peter J. Koudstaal, H. M. den Hertog, Elizabeth Osei, Susanne Fonville, Adrienne A.M. Zandbergen
Publikováno v:
Journal of Neurology, 265(6), 1426-1431. D. Steinkopff-Verlag
OBJECTIVES Hyperglycemia on admission and diabetes mellitus type II are associated with unfavorable outcome in stroke patients. We studied whether impaired fasting glucose (IFG) is associated with unfavorable outcome in ischemic stroke patients treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876a6a5019567f99fe2bdb2cdfcf0dd2
https://pure.eur.nl/en/publications/3496228f-b0fc-48e1-b73c-e0644aea24a5
https://pure.eur.nl/en/publications/3496228f-b0fc-48e1-b73c-e0644aea24a5
Autor:
Peter J. Koudstaal, Ale Algra, Sefanja Achterberg, Sarah E. Vermeer, Diederik W.J. Dippel, Heleen M. den Hertog, L. J. Kappelle, Adrienne A.M. Zandbergen
Publikováno v:
International Journal of Stroke, 10(1), 105-109. SAGE Publications Ltd
International Journal of Stroke, 10(1), 105. Blackwell Publishing Asia Pty Ltd
International Journal of Stroke, 10(1), 105. Blackwell Publishing Asia Pty Ltd
Background and purpose We aimed to assess the safety, feasibility, and effects on glucose metabolism of treatment with metformin in patients with TIA or minor ischemic stroke and impaired glucose tolerance. Methods We performed a multicenter, randomi
Publikováno v:
Cerebrovascular Diseases. 37:393-400
Background: The prevalence of diabetes is emerging worldwide and is an important modifiable risk factor for stroke. People with prediabetes, an intermediate metabolic state between normal glucose metabolism and diabetes, have a tenfold increased risk
Autor:
Charles DeCarli, Pierre Etienne Leblanc, Yan Borné, Yukako Yazawa, Yasuhiro Ishibashi, Ying Kuen Cheung, Mitsuhiro Yoshita, Clinton B. Wright, Denis Ducreux, Joshua Z. Willey, Guillaume Saliou, Yeseon P. Moon, Druckerei Stückle, Yasushi Okada, Kozo Tanno, Christian Marescaux, Michael J. Lynn, Zoran Rumboldt, Peter J. Koudstaal, Fredrik Björklund, Anna Graipe, Heleen M. den Hertog, Akira Ogawa, Hisatomi Arima, Bernard Geny, Kenta Kawata, Eisuke Furui, Jean-Paul Armspach, Rémy Beaujeux, Catherine Ract, Valérie Lauer, Gunnar Engström, Kiyomi Sakata, Yuki Yoshida, John Berntsson, Shyam Prabhakaran, Kuniaki Ogasawara, Nobuyuki Yasui, Yasuhiro Hasegawa, Alejandro M. Brunser, Ryo Itabashi, Maria Matheus, Stina Jakobsson, Kazuyuki Nagatsuka, Hannah Gardener, Elisabet Zia, Motoyuki Nakamura, Olle Melander, Toshiyuki Uehara, Etsuro Mori, Thomas Mooe, Verónica V. Olavarría, Pablo M. Lavados, Marc I. Chimowitz, Kazuyoshi Itai, Stephane Heritier, Masaki Ohsawa, Kazuo Minematsu, Toshiyuki Onoda, Elena López-Cancio, Olivier Rouyer, Shoichiro Sato, Shinichi Omama, Mitchell S.V. Elkind, Satz Mengensatzproduktion, Daniel Huber, Bo Hedblad, Cécile Cauquil, Susanne Fonville, Valérie Wolff, Ralph L. Sacco, David S Liebeskind, Nicolas Meyer, Adrienne A.M. Zandbergen, Craig S. Anderson, Jose G. Romano, Tanya N. Turan, George Cotsonis, Paula Muñoz-Venturelli, Monica Manisor, Marie Théaudin
Publikováno v:
Cerebrovascular Diseases. 37:I-VI
Autor:
H. M. den Hertog, Elizabeth Osei, Adrienne A.M. Zandbergen, Debbie Beumer, Jelis Boiten, Yvo B.W.E.M. Roos, Puck S. S. Fransen, Diederik W.J. Dippel, Peter J. Koudstaal, Olvert A. Berkhemer, Wouter J. Schonewille, R. J. van Oostenbrugge
Publikováno v:
Journal of the Neurological Sciences, 371, 1-5. Elsevier
Journal of the Neurological Sciences, 371, 1-5. Elsevier Science
Journal of the neurological sciences, 371, 1-5. Elsevier
Journal of the Neurological Sciences, 371, 1-5. Elsevier Science
Journal of the neurological sciences, 371, 1-5. Elsevier
Background Limited data are available on the impact of fasting glucose on outcome after intra-arterial treatment (IAT). We studied whether hyperglycemia on admission and impaired fasting glucose (IFG) are associated with unfavorable outcome after IAT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6554648c0348e3261a6b03246f4e9fb
https://pure.eur.nl/en/publications/8983d257-171b-4aa4-981b-4b48a2f08b35
https://pure.eur.nl/en/publications/8983d257-171b-4aa4-981b-4b48a2f08b35
Autor:
Linda E.M. van den Berg, Johanna M. P. Van den Hout, Juna M. de Vries, Carine I. van Capelle, Ans T. van der Ploeg, Adrienne A.M. Zandbergen, Wim C. J. Hop, M. Carola Zillikens, Arnold J. J. Reuser
Publikováno v:
Bone. 47:643-649
article i nfo Pompe disease is an inherited metabolic myopathy caused by de!ciency of acid alpha-glucosidase. The introduction of enzyme replacement therapy as treatment for the disease may change prospects for patients and may require that more atte
Autor:
Aart H. Bootsma, Marinus G. A. Baggen, Joop A. M. J. L. Janssen, Eric Boersma, Steven W. J. Lamberts, Adrienne A.M. Zandbergen
Publikováno v:
Clinical Endocrinology, 64(2), 203-208. Wiley-Blackwell Publishing Ltd
Summary Objective Losartan has been shown to protect the diabetic kidney, at least partly independent of changes in blood pressure. Imbalances in the IGF-I system are associated with the development of diabetic nephropathy. We investigated whether re